FDA issues public health advisory recommending limited use of COX-2 inhibitors.
D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D004335:Drug and Narcotic Control; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors